Page last updated: 2024-08-21

quinazolines and blister

quinazolines has been researched along with blister in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Date, DA; Kaur, H; Stiff, AC; Taylor, WR1
Chang, TY; Chao, YS; Chiu, HC; Hsu, JT; Huang, CT1
Espasandin, YR; Glembotsky, AC; Goette, NP; Grodzielski, M; Heller, PG; Lev, PR; Marta, RF; Molinas, FC1

Other Studies

3 other study(ies) available for quinazolines and blister

ArticleYear
Analysis of mitotic phosphorylation of borealin.
    BMC cell biology, 2007, Jan-22, Volume: 8

    Topics: Amino Acid Substitution; Aurora Kinase B; Aurora Kinases; Benzamides; CDC2 Protein Kinase; Cell Cycle Proteins; Centromere; Chromosomal Proteins, Non-Histone; Chromosome Segregation; Consensus Sequence; Cycloheximide; G2 Phase; HeLa Cells; Heterocyclic Compounds, 4 or More Rings; Humans; Inhibitor of Apoptosis Proteins; Interphase; Metaphase; Microtubule-Associated Proteins; Mitosis; Multiprotein Complexes; Mutagenesis, Site-Directed; Mutation, Missense; Neoplasm Proteins; Nocodazole; Okadaic Acid; Phosphoprotein Phosphatases; Phosphorylation; Phosphoserine; Piperazines; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Synthesis Inhibitors; Quinazolines; Recombinant Fusion Proteins; Sodium Fluoride; Spindle Apparatus; Substrate Specificity; Survivin; Transfection

2007
EGFR and myosin II inhibitors cooperate to suppress EGFR-T790M-mutant NSCLC cells.
    Molecular oncology, 2012, Volume: 6, Issue:3

    Topics: Actins; Apoptosis; Blotting, Western; Cell Line; Cell Nucleus; Cell Proliferation; Cyclooxygenase 2; ErbB Receptors; Flow Cytometry; Heterocyclic Compounds, 4 or More Rings; Humans; Immunoprecipitation; Molecular Motor Proteins; Myosin Heavy Chains; Myosin Type II; Protein Binding; Quinazolines; Real-Time Polymerase Chain Reaction; RNA Interference

2012
Anagrelide platelet-lowering effect is due to inhibition of both megakaryocyte maturation and proplatelet formation: insight into potential mechanisms.
    Journal of thrombosis and haemostasis : JTH, 2015, Volume: 13, Issue:4

    Topics: Blood Platelets; Case-Control Studies; Cell Adhesion Molecules; Cells, Cultured; Cyclic AMP; Dose-Response Relationship, Drug; Fetal Blood; Hematopoietic Stem Cells; Heterocyclic Compounds, 4 or More Rings; Humans; Megakaryocytes; Microfilament Proteins; Myosins; Phosphodiesterase 3 Inhibitors; Phosphoproteins; Phosphorylation; Platelet Aggregation Inhibitors; Quinazolines; Signal Transduction; Thrombocythemia, Essential; Thrombopoiesis; Time Factors; Transcription Factors

2015